Expert view: Chinese healthcare industry entering a 'new normal'?
This article was originally published in Scrip
Executive Summary
Two years after the GSK scandal broke in China, a national campaign against corruption is marching on in the country, and a series of recent events suggests that Chinese authorities are determined to clean up the healthcare industry and bring in a 'new normal'. For multinational companies, the shakeup should come as welcome news, and it is time to devise strategies to prepare for a new phase of reform in the country, writes Pengfei Lu, director of corporate strategy at the research services company Wuxi AppTec.